** Jefferies says, with current U.S. flu season largely progressing as expected, it helps Fisher & Paykel Healthcare FPH.NZ meet its FY26 guidance

** New Zealand-based medical equipment maker manufactures products for use in acute and chronic respiratory care and has operations in the U.S.

** Jefferies notes the CDC continues to expect a moderate 2025-26 season, but flags elevated flu incidence amongst children

** Brokerage also notes co's estimate that less than 5% of its hospital business is attributable to seasonal effects

** Stock up 4.1% so far this year, as of last close

(Reporting by Nikita Maria Jino in Bengaluru)

((Nikita.Jino@thomsonreuters.com))